Hohance Chemistry | Looshine (Shanghai) Pharmaceutical Technology Co., Ltd
One of the Professional Scientific Chemical Suppliers
Hohance Chemistry | Looshine (Shanghai) Pharmaceutical Technology Co., Ltd
One of the Professional Scientific Chemical Suppliers
Founded in 2009, Hohance is a research-driven pharmaceutical and chemical enterprise engaged in custom synthesis, process development, pilot scale-up, and commercial manufacturing.
With a 3,000 m² R&D center in Shanghai, production bases in Anhui and Shandong, and a cGMP-oriented operating framework, the company supports customers with integrated technical and manufacturing capabilities across the full project lifecycle.
Shanghai Hohance Chemical Co., Ltd., together with its subsidiary Looshine (Shanghai) Pharmaceutical Technology Co., Ltd., is a high-tech enterprise focused on the development, production, and commercialization of fine chemicals and pharmaceutical-related products. Since its establishment, the company has adhered to a reputation-first, quality-first philosophy and has continued to invest in technical capability, process development, and customer service.
Hohance’s R&D center is located in the Songjiang Science and Technology Innovation Center in Shanghai. Equipped with research laboratories and process development laboratories, the center covers a total area of 3,000 square meters. The company has developed technical strengths in applied chemistry, OLED intermediates, pharmaceutical intermediates, and other specialty chemical fields.
In addition to its Shanghai R&D operations, Hohance has established modern production bases in Shanghai, Anhui, and Shandong. Supported by an experienced process development team, the company has built an integrated capability platform spanning laboratory research, pilot verification, and industrial-scale manufacturing. This structure enables Hohance to support a broad range of custom synthesis and contract manufacturing requirements.
Over the years, Hohance and Looshine have established a solid reputation for technical capability, product quality, and service reliability. The company has been certified to ISO9001, ISO14001, and ISO45001 standards, has obtained more than 30 invention patents, and has successfully passed on-site audits by leading domestic, Japanese, and European companies.
Hohance has also established long-term relationships with pharmaceutical R&D organizations, industrial customers, and leading research institutions in China and overseas, including the Institute of Organic Chemistry of the Chinese Academy of Sciences, China Pharmaceutical University, Nanjing Normal University, and Cornell University. These collaborations reflect the company’s emphasis on professionalism, integrity, and long-term technical development.
Hohance continues to strengthen the transparency of its operating profile by presenting clearer information on its organizational scale, technical resources, manufacturing footprint, and compliance framework. The company serves customers in specialty chemicals, pharmaceutical intermediates, OLED intermediates, and customized synthesis projects through an integrated research and manufacturing model.
Hohance operates an integrated platform connecting laboratory research, process development, pilot-scale verification, and commercial manufacturing. With its 3,000 m² Shanghai R&D center and production bases in Anhui and Shandong, the company is able to support project transition from early-stage development to industrial-scale supply with improved continuity and coordination.
This operating model is designed to strengthen communication between technical and manufacturing teams while improving efficiency in process transfer, scale-up, and commercial execution.
Hohance supports projects across the full development cycle, from early-stage synthesis and laboratory verification to pilot campaigns and industrial production. This capability enables the company to respond to a wide range of customer requirements while maintaining a practical balance between technical precision, manufacturing consistency, and delivery reliability.
With annual production capability ranging from gram-level development to hundreds of tons, Hohance provides a flexible manufacturing foundation for customers seeking both specialized development support and dependable long-term supply.
Innovation remains an important part of Hohance’s long-term development strategy. Through continued investment in synthetic chemistry, process optimization, analytical understanding, and scalable manufacturing technologies, the company has built a technical foundation that supports differentiated customer requirements and sustainable growth.
To date, Hohance has obtained more than 30 national invention patents, reflecting its commitment to technical capability, applied innovation, and long-term industrial value creation.
Hohance continues to strengthen its quality and compliance systems in order to support customers with reliable, auditable, and scalable development and manufacturing services. Its certification profile reflects a structured approach to operational management and long-term process improvement.
In addition to formal certifications, Hohance’s reputation has been supported by successful customer audits, long-term business relationships, and continued investment in process capability, technical talent, and manufacturing infrastructure.
Hohance has served customers in more than 30 countries and completed over 500 projects, developing long-term relationships with pharmaceutical companies, specialty chemical customers, and research institutions in China and overseas.
The company’s customer portfolio includes recognized organizations such as Jiuzhou Pharmaceutical, Hutchison Pharmaceutical (Shanghai), Canon, Kyocera, Apollo Scientific, Lavi Pharma, and Merck. Through these relationships, Hohance continues to strengthen its role as a dependable technical and manufacturing partner for global customers.
Looking ahead, Hohance will continue to invest in scientific innovation, manufacturing capability, and customer-oriented execution. The company remains committed to strengthening its position in the pharmaceutical and specialty chemical sectors while delivering long-term value through quality, responsiveness, and disciplined operational development.
